{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:18:45Z","timestamp":1760746725974,"version":"build-2065373602"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>PTEN hamartoma tumor syndrome (PHTS) is a rare, multisystem disorder caused by germline pathogenic variants in the PTEN gene, predisposing individuals to various malignancies, including breast cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>We describe a 26-year-old woman with longstanding bilateral palpable breast masses and spontaneous bloody nipple discharge. Imaging revealed numerous cysts and masses, predominantly in the right breast. Multiple biopsies showed benign papilloma with focal atypical ductal hyperplasia (ADH), while total mastectomy specimens revealed multifocal, poorly differentiated, triple-negative invasive carcinoma. An axillary lymph node contained ectopic breast tissue with associated papillary proliferation. Genetic testing identified a pathogenic germline <jats:italic>PTEN<\/jats:italic> variant (c.209\u2009+\u20094_209\u2009+\u20097delAGTA), confirming PTEN hamartoma tumor syndrome (PHTS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This case underscores the importance of considering PHTS in young patients presenting with extensive papillomatosis and other unusual breast pathologic findings, even in the absence of a family history of cancer. Early recognition enables timely genetic counseling, confirmatory testing, and implementation of appropriate surveillance and management strategies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13000-025-01715-1","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T10:51:27Z","timestamp":1760698287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Invasive breast carcinoma in a patient with PHTS: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Haiying","family":"Zhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Fischbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanxin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma","family":"Krishnamurti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"1715_CR1","doi-asserted-by":"crossref","unstructured":"Pilarski R. PTEN Hamartoma tumor syndrome: a clinical overview. Cancers (Basel). 2019;11(6).","DOI":"10.3390\/cancers11060844"},{"issue":"4","key":"1715_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1136\/jmedgenet-2012-101339","volume":"50","author":"V Bubien","year":"2013","unstructured":"Bubien V, et al. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome. J Med Genet. 2013;50(4):255\u201363.","journal-title":"J Med Genet"},{"issue":"1","key":"1715_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ajmg.b.32610","volume":"177","author":"TB Balci","year":"2018","unstructured":"Balci TB, et al. Broad spectrum of neuropsychiatric phenotypes associated with white matter disease in PTEN hamartoma tumor syndrome. Am J Med Genet B Neuropsychiatr Genet. 2018;177(1):101\u20139.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"3","key":"1715_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ajmg.a.63070","volume":"191","author":"X Wang","year":"2023","unstructured":"Wang X, Moore C, Bao Y. Benign goiters requiring thyroidectomy as the signal for PTEN hamartoma tumor syndrome diagnosis. Am J Med Genet A. 2023;191(3):753\u20139.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"1715_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1056\/NEJMoa1910549","volume":"382","author":"P Schmid","year":"2020","unstructured":"Schmid P, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382(9):810\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"1715_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10689-013-9674-3","volume":"13","author":"MH Nieuwenhuis","year":"2014","unstructured":"Nieuwenhuis MH, et al. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome. Fam Cancer. 2014;13(1):57\u201363.","journal-title":"Fam Cancer"},{"issue":"2","key":"1715_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","volume":"18","author":"MH Tan","year":"2012","unstructured":"Tan MH, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res. 2012;18(2):400\u20137.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1715_CR8","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.ajhg.2022.07.005","volume":"109","author":"T Brewer","year":"2022","unstructured":"Brewer T, et al. Exome sequencing reveals a distinct somatic genomic landscape in breast cancer from women with germline PTEN variants. Am J Hum Genet. 2022;109(8):1520\u201333.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1715_CR9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/cncr.29106","volume":"121","author":"H Mahdi","year":"2015","unstructured":"Mahdi H, et al. Germline PTEN, SDHB-D, and KLLN alterations in endometrial cancer patients with Cowden and Cowden-like syndromes: an international, multicenter, prospective study. Cancer. 2015;121(5):688\u201396.","journal-title":"Cancer"},{"issue":"5","key":"1715_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/cncr.29107","volume":"121","author":"ZK Stadler","year":"2015","unstructured":"Stadler ZK, Robson ME. Inherited predisposition to endometrial cancer: moving beyond Lynch syndrome. Cancer. 2015;121(5):644\u20137.","journal-title":"Cancer"},{"issue":"3","key":"1715_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/PAS.0000000000000115","volume":"38","author":"FI Boulos","year":"2014","unstructured":"Boulos FI, et al. Intranodal papillary epithelial proliferations: a local process with a spectrum of morphologies and frequent association with papillomas in the breast. Am J Surg Pathol. 2014;38(3):383\u20138.","journal-title":"Am J Surg Pathol"},{"key":"1715_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1746-1596-5-17","volume":"5","author":"R Dzodic","year":"2010","unstructured":"Dzodic R, et al. Intraductal papilloma of ectopic breast tissue in axillary lymph node of a patient with a previous intraductal papilloma of ipsilateral breast: a case report and review of the literature. Diagn Pathol. 2010;5:17.","journal-title":"Diagn Pathol"},{"issue":"21","key":"1715_CR13","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/jnci\/djt277","volume":"105","author":"R Pilarski","year":"2013","unstructured":"Pilarski R, et al. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013;105(21):1607\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1715_CR14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/cncr.35238","volume":"130","author":"MB Nierengarten","year":"2024","unstructured":"Nierengarten MB. FDA approves capivasertib with fulvestrant for breast cancer. Cancer. 2024;130(6):835\u20136.","journal-title":"Cancer"},{"issue":"3","key":"1715_CR15","doi-asserted-by":"publisher","first-page":"e12372","DOI":"10.1002\/2056-4538.12372","volume":"10","author":"H Salaun","year":"2024","unstructured":"Salaun H, et al. The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features. J Pathol Clin Res. 2024;10(3):e12372.","journal-title":"J Pathol Clin Res"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01715-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01715-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01715-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T10:51:28Z","timestamp":1760698288000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01715-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1715"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01715-1","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"26 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the IRB at Yale University. This case study was properly de-identified, therefore ethics approval and consent were waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}